Rare diseases
Investigational molecules
Locations
Via Uberto Visconti Di Modrone 18, 20122 Milan, Italy
Aavantgarde Bio S.r.l. focuses its research efforts on advancing cancer treatment through innovative therapeutic approaches. The company's clinical development program centers on addressing critical unmet needs in solid tumor malignancies, with particular emphasis on cancers affecting the gastrointestinal system.
The sponsor's research portfolio demonstrates a commitment to developing treatments for patients with advanced gastric cancer, targeting populations where existing therapeutic options may be limited. This work reflects a strategic focus on gastrointestinal oncology and the development of novel interventions for difficult-to-treat malignancies.
Aavantgarde Bio S.r.l. runs clinical trials in conditions such as Stargardt's disease, Retinitis pigmentosa, Usher's syndrome, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
